截至2025年6月30日止六個月的 中期業績公告 知乎（「本公司」）董事（「董事」）會（「董事會」）欣然宣佈，本公司、其附屬公司及 綜合聯屬實體（「本集團」或「知乎」）截至2025年6月30日止六個月（「報告期間」） 的未經審計簡明中期合併業績（「未經審計中期業績」），連同2024年同期的比較數 字。該等中期業績乃根據美國公認會計準則（「美國公認會計準則」）編製。報告期 間的未經審計簡明中期合併財務資料已由本公司獨立核數師羅兵咸永道會計師事 務所根據國際審閱委聘準則第2410號「 由實體獨立核數師審閱中期財務資料 」進行 審閱。 於本公告內，「我們」指本公司及（倘文義另有所指）本集團（定義見「一般資料」一 節）。 1 財務表現摘要 | | 截至6月30日止六個月 | | | | --- | --- | --- | --- | | | 2025年 | 2024年 | 變動(%) | | | （未經審計）（未經審計） | | | | | （人民幣千元， | 百分比除外） | | | 總收入 | 1,446,559 | 1,894,673 | (23.7)% | | 毛利 | 899,287 | 1,100,023 ...

內幕消息 截至2025年6月30日止季度 未經審計財務業績 本公告乃根據香港聯合交易所有限公司（「香港聯交所」）證券上市規則第13.09條 及證券及期貨條例（第571章）第XIVA部刊發。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 Zhihu Inc. （於開曼群島註冊成立以不同投票權控制的有限責任公司） （紐交所代號：ZH；聯交所代號：2390） 知乎（「本公司」）欣然宣佈本公司及其附屬公司及綜合聯屬實體截至2025年6月 30日止三個月的未經審計簡明合併業績。 本公司欣然宣佈，根據美國證券交易委員會（「美國證監會」）適用規則刊發的本公 司及其附屬公司及綜合聯屬實體截至2025年6月30日止三個月的未經審計簡明合 併業績（「第二季度業績」）。 第二季度業績乃根據美國公認會計準則（有別於國際財務報告準則）編製。 本公告附表I為本公司於2025年8月27日（美國東部時間）就第二季度業績刊發的新 聞稿全文，其中部分內容可能構成本公司的重大內幕消息。 ...

Group 1 - US stock indices opened slightly lower, with Dow down 0.13%, S&P 500 down 0.06%, and Nasdaq down 0.04% [1] - Eli Lilly's oral GLP-1 drug orforglipron achieved positive results in Phase 3 clinical trials, leading to plans for a global regulatory submission within the year [4] - South Korea's Korean Air signed a $50 billion procurement agreement with Boeing for 103 new-generation aircraft and engine maintenance services over the next 20 years [5] Group 2 - Beike reported a 11.3% year-on-year increase in revenue for Q2, totaling 26 billion yuan, while NON-GAAP net profit decreased by 32.4% to 1.82 billion yuan [6]

Core Viewpoint - Zhihu's stock price increased by 4.8% on August 19, reaching $5.135 per share, with a total market capitalization of $453 million. However, the company's revenue for the fiscal year ending March 31, 2025, is projected to decline by 24.06% year-on-year to 730 million RMB, while the net profit attributable to shareholders is expected to show a significant increase of 93.88% year-on-year, amounting to a loss of 10.094 million RMB [1]. Group 1 - Zhihu is a leading online content community in China, evolving from a Q&A platform to one of the largest integrated content communities since its launch in 2010 [1][2]. - The company is dual-listed on the New York Stock Exchange (NYSE: ZH) and the Hong Kong Stock Exchange (HKEX: 2390) [1]. - Zhihu is set to release its fiscal year 2025 interim report on August 27, 2023 [1]. Group 2 - The company focuses on expanding its content and services to meet the diverse needs of users, content creators, and business partners, establishing a content-centric business model [2]. - Zhihu aims to create a balanced ecosystem between content creators and users, fostering a positive cycle of content creation and consumption [3]. - The company has developed diverse monetization channels, including marketing services, paid memberships, and vocational training, enhancing user experience and community governance [3].

Group 1 - Nasdaq China Golden Dragon Index opened slightly higher on August 19 [1] - Zhihu increased by over 7%, Century Internet rose by over 2%, and both iQIYI and Xpeng Motors gained over 1% [1] - Xunlei experienced a decline of over 6% [1]

Core Viewpoint - Zhihu (ZH.US) experienced an 8% increase in stock price, reaching $5.30, as it prepares for a board meeting on August 27 to consider and approve mid-term performance [1] Group 1: Stock Performance - Zhihu's stock rose by 8% to $5.30 on Tuesday [1] Group 2: Institutional Investment - Fidelity International significantly increased its stake in Zhihu-W (02390), raising its holdings from 4.576 million shares at the end of March to 12.489 million shares as of July 25 [1] - Fidelity's ownership in Zhihu's total issued Class A ordinary shares increased from 1.83% to 5.01% [1] - This marks the third time Fidelity International has increased its holdings in Zhihu since the end of 2024 [1]

Core Viewpoint - Zhihu (ZH.US) experienced an 8% increase in stock price, reaching $5.30, as it plans to hold a board meeting on August 27 to consider and approve its mid-term performance [1] Group 1: Stock Performance - Zhihu's stock rose by 8% to $5.30 on Tuesday [1] Group 2: Institutional Investment - Fidelity International significantly increased its stake in Zhihu-W (02390), raising its holdings from 4.576 million shares at the end of March to 12.489 million shares by July 25 [1] - Fidelity's ownership in Zhihu's total outstanding Class A ordinary shares increased from 1.83% to 5.01% [1] - This marks the third time Fidelity International has increased its stake in Zhihu since the end of 2024 [1]

Core Viewpoint - Zhihu's stock opened up by 5.31% on August 19, with a total market capitalization of $455 million, despite a year-over-year revenue decline of 24.06% to 730 million RMB as of March 31, 2025, while net profit attributable to shareholders increased by 93.88% to -10.094 million RMB [1][2]. Group 1: Company Overview - Zhihu is a leading online content community in China, evolving from a Q&A platform to one of the largest integrated content communities since its launch in 2010 [2][3]. - The company is dual-listed on the New York Stock Exchange (NYSE: ZH) and the Hong Kong Stock Exchange (HKEX: 2390) [2]. Group 2: Business Model and Strategy - Zhihu focuses on expanding content and services to meet the diverse needs of users, content creators, and business partners, establishing a content-centric business model [2][3]. - The company aims to create a balanced ecosystem between content creators and users, fostering a positive cycle of interaction and knowledge sharing [3]. Group 3: Community and User Engagement - Zhihu emphasizes user experience and community governance, which strengthens its brand and attracts more users and content creators [3]. - The company has developed diversified monetization channels, including marketing services, paid memberships, and vocational training, enhancing its leadership position in the industry [3].

Market Performance - The Hang Seng Index closed down by 0.21% [1] - The Hang Seng Tech Index fell by 0.67% [1] Company Movements - Oriental Selection experienced a significant drop, closing down over 20% after a peak increase of 23% during the day [1] - Biopharmaceutical stocks continued to decline, with Genscript Biotech Corporation (歌礼制药-B) dropping over 15%, Peijia Medical (派格生物医药-B) down over 8%, and Hengrui Medicine (恒瑞医药) falling over 5% [1] - Zhihu saw a notable increase, rising over 23% [1]

知乎-W(02390)盘中涨超16%，截至发稿，涨16.65%，报13.59港元，成交额426.5万港元。 消息面上，知乎-W拟于8月27日举行董事会会议考虑及批准中期业绩。此前，知乎-W发布截至2025年3 月31日止季度业绩，该集团期内取得总收入7.3亿元(人民币，下同)；毛利率由2024年同期的56.6%提高 至61.8%；净亏损1010万元，同比收窄93.9%；每股基本净亏损0.04元。知乎董事长兼行政总裁周源表 示，公司自上市以来首次于第一季度取得非公认会计准则净利润，延续了第四季度的盈利势头。这一成 就体现了公司精细化营运策略的成效，以及人工智能在知乎生态系统中的深度融合。 值得一提的是，7月30日，全球知名投资机构富达国际发布的联交所权益披露表格显示，截至7月25日富 达基金大幅增持知乎-W，持股从今年3月末的457.6万普通股增长至1248.9万普通股，在知乎全部发行在 外A类普通股中的占比，从1.83%增长至5.01%。这也是富达国际自2024年末以来，第三次增持知乎- W。除长线基金连续增持之外，今年以来，中信里昂、花旗集团、中金公司、广发证券等分析师相继调 高知乎评级及目标价，看好其未来 ...